AB012. Brachytherapy for localized prostate cancer
AB012. Brachytherapy for localized prostate cancer
Podium Lecture
AB012. Brachytherapy for localized prostate cancer
Yong Xu, Yong Yang
Department of Urology, the General Hospital of PLA, Beijing 100853, China
Background: To evaluate the security and effect of brachytherapy for localized prostate cancer.
Methods: Forty five patients with Tl–T2 prostate cancer were treated with real-time transperineal ultrasound-guide 125I seeds prostate implantation.
Results: The median operation time was 90 min, the median number of I seeds used was 56. The follow up time was 12–48 months, the cases of PSA <1 µg/L were 29, PSA 1–2 µg/L were 11 and PSA ≥2 µg/L were 5.
Conclusions: Brachytherapy for localized prostate cancer is safe and effective.
Keywords: Brachytherapy; prostate; cancer
doi: 10.21037/tau.2016.s012
Cite this abstract as: Xu Y, Yang Y. Brachytherapy for localized prostate cancer. Transl Androl Urol 2016;5(Suppl 1):AB012. doi: 10.21037/tau.2016.s012